European Companies Search Engine
State Aid (€1,635,960): R&D&I-scheme Flanders. Prolongation of an existing R&D&I-scheme. Belgium (Flanders) Sat26 Jan 2017 State Aid Transparency (Direct grant)
Overview
Text
| Country | Belgium |
| Language | Dutch |
| Aid Measure Title | R&D&I-scheme Flanders. Prolongation of an existing R&D&I-scheme. Belgium (Flanders) (en: R & D & I-scheme Flanders. Extension of an existing R & D & I-scheme. Belgium (Flanders)) |
| SA.Number | SA.33193 |
| Ref-no. | TM-10002870 |
| National ID | 0632.474.939 |
| Beneficiary National ID Type | KBO/BCE |
| Name of the beneficiary | CONFO THERAPEUTICS |
| Beneficiary Type | Small and medium-sized entreprises |
| Region | VLAAMS GEWEST |
| Sector (NACE) | Other research and experimental development on natural sciences and engineering |
| Aid Instrument | Direct grant |
| Objectives of the Aid | Research and development |
| Date of Granting | 26/01/2017 |
| Aid element, expressed as full amount | 1,635,960.00 EUR |
| Granting Authority Name | VLAIO |
| Co-finance | ✗ |
| Covid-19 | ✗ |
| Entrusted Entity | |
| Financial Intermediaries |
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Confo Therapeutics N.V., Ghent, Belgium.
The visualizations for "Confo Therapeutics - State Aid (€1,635,960): R&D&I-scheme Flanders. Prolongation of an existing R&D&I-scheme. Belgium (Flanders)"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
